Cancer Cell International · 2013 · 90 citations · 14 references
MedicineCancer BiologyOncologyGene ExpressionMetastasisMolecular OncologyBreast Cancer OncologyMicrorna BiologyMicrorna-mediated RegulationMolecular Tumor ProfilingNoncoding Rna In CancerRna InterferenceCell Migration AssaysCyclin RegulationDual-luciferase AssaysLuciferase Reporter AssaysMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerQuantitative Polymerase Chain Reaction Assays
BACKGROUND: MicroRNAs are a class of endogenous single strand non-coding RNAs that are involved in many important physiological and pathological processes. The purpose of this study was to examine the expression levels of miR-497 in human breast cancer and its function in MDA-MB-231 breast cancer cells. METHODS: Quantitative polymerase chain reaction was used to measure the expression levels of miR-497 in 40 breast cancer specimens and adjacent normal breast tissues. MTT assays, colony formation assays, wound healing assays, transwell assays and cell cycle assays were used to explore the potential function of miR-497 in MDA-MB-231 breast cancer cells. Dual-luciferase reporter assays were performed to analyze the regulation of putative target of miR-497, and western blot assays were used to validate the dual-luciferase results. RESULTS: The expression of miR-497 in breast cancer specimens was lower than adjacent normal tissues (P < 0.05). Overexpression of miR-497 inhibited cellular growth, suppressed cellular migration and invasion, and caused a G1 arrest. Dual-luciferase reporter assays showed that miR-497 binds the 3'-untranslated region (3'-UTR) of cyclin E1, suggesting that cyclin E1 is a direct target of miR-497. Western blot assays confirmed that overexpression of miR-497 reduced cyclin E1 protein levels. CONCLUSIONS: MiR-497 may act as a tumor suppressor gene in breast cancer. Inhibited cellular growth, suppressed cellular migration and invasion, and G1 cell cycle arrest were observed upon overexpression of miR-497 in cells, possibly by targeting cyclin E1. These results indicate miR-497 could be considered a therapeutic target for the development of treatment for breast cancer.
14
Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing
Gunter Meister, Markus Landthaler, Yair Dorsett et al. · RNA · 2004 · 618 citations · Full text
Cyclin E and Survival in Patients with Breast Cancer
Khandan Keyomarsi, Susan L. Tucker, Thomas A. Buchholz et al. · New England Journal of Medicine · 2002 · 557 citations · Full text
Medicine, Cell Biology, Oncology +15
Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
Dan Li, Yulan Zhao, Changxing Liu et al. · Clinical Cancer Research · 2011 · 340 citations · Full text
miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
Wei Zhu, Danxia Zhu, Shiqiang Lu et al. · Medical Oncology · 2011 · 202 citations
Medicine, Cancer Biology, Oncology +13